Total planned funding: $314,554,022
Allocations
Countries/Regions
Eswatini | $314,554,022 |
Organizational Types
Private Contractor | $80,301,896 |
University | $57,755,746 |
Unknown | $55,418,306 |
NGO | $55,413,603 |
Own Agency | $37,880,078 |
Host Country Government Agency | $11,382,247 |
FBO | $10,806,488 |
Multi-lateral Agency | $3,030,564 |
Other USG Agency | $2,515,094 |
Implementing Agency | $50,000 |
Program Areas
Care | $93,564,050 |
Treatment | $80,969,808 |
Prevention | $58,196,885 |
Governance and Systems | $36,953,569 |
Testing | $23,460,420 |
Management and Operations | $21,409,290 |
Budget Codes
HTXS: Treatment: Adult Treatment | $68,044,454 |
HBHC: Care: Adult Care and Support | $35,769,128 |
HKID: Care: Orphans and Vulnerable Children | $32,917,220 |
HVCT: Testing: HIV Testing and Counseling | $23,460,420 |
HVMS: Management and Operations | $21,409,290 |
HVOP: Sexual Prevention: Other Sexual Prevention | $20,806,577 |
HVSI: Strategic Information | $19,301,844 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,539,990 |
HVTB: Care: TB/HIV | $17,198,159 |
OHSS: Health Systems Strengthening | $12,161,593 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $9,145,609 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,764,709 |
PDTX: Treatment: Pediatric Treatment | $8,359,376 |
PDCS: Care: Pediatric Care and Support | $7,679,543 |
HLAB: Laboratory Infrastructure | $5,490,132 |
HTXD: Treatment: ARV Drugs | $4,565,978 |
HMBL: Biomedical Prevention: Blood Safety | $940,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$46,572,370
Countries/Regions
Pact, Inc.:
$37,668,259
Countries/Regions
Not Available:
$37,108,440
Countries/Regions
Chemonics International:
$16,579,695
Countries/Regions